<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fuchs BB</submitter><funding>Brown-Brazil Initiative</funding><funding>NIDA NIH HHS</funding><funding>National Institutes of Health (US)</funding><funding>Astellas Pharma US (US)</funding><funding>Natural Science Grant of China</funding><pagination>17-25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4676791</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>181(1-2)</volume><pubmed_abstract>The echinocandin family of drugs is well characterized for antifungal function that inhibits β-D-glucan synthesis. The aim of this work was to study whether micafungin, a member of the echinocandin family, elicits additional activities that prime the host's immune response. We found that in a Galleria mellonella model, prophylactic treatment with micafungin extended the life of Staphylococcus aureus-infected larvae (a pathogen to which the drug demonstrates no direct antimicrobial activity) compared to insects that did not receive micafungin (P &lt; 0.05). The inhibition of pathogens in the G. mellonella infection model was characterized by a 2.43-fold increase in hemocyte density, compared to larvae inoculated with PBS. In a murine model where animals were provided micafungin prophylaxis 3 d</pubmed_abstract><journal>Mycopathologia</journal><pubmed_title>Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice.</pubmed_title><pmcid>PMC4676791</pmcid><funding_grant_id>T32 DA013911</funding_grant_id><funding_grant_id>T-32DA013911</funding_grant_id><funding_grant_id>81102480</funding_grant_id><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Mylonakis E</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Fuchs BB</pubmed_authors><pubmed_authors>Hendricks G</pubmed_authors><pubmed_authors>Rajamuthiah R</pubmed_authors><pubmed_authors>Johnston T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice.</name><description>The echinocandin family of drugs is well characterized for antifungal function that inhibits β-D-glucan synthesis. The aim of this work was to study whether micafungin, a member of the echinocandin family, elicits additional activities that prime the host's immune response. We found that in a Galleria mellonella model, prophylactic treatment with micafungin extended the life of Staphylococcus aureus-infected larvae (a pathogen to which the drug demonstrates no direct antimicrobial activity) compared to insects that did not receive micafungin (P &lt; 0.05). The inhibition of pathogens in the G. mellonella infection model was characterized by a 2.43-fold increase in hemocyte density, compared to larvae inoculated with PBS. In a murine model where animals were provided micafungin prophylaxis 3 d</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Feb</publication><modification>2025-04-21T19:27:46.244Z</modification><creation>2019-03-27T02:05:01Z</creation></dates><accession>S-EPMC4676791</accession><cross_references><pubmed>26384671</pubmed><doi>10.1007/s11046-015-9940-z</doi></cross_references></HashMap>